Advice to Hospira employees

Quote

Anonymous

Guest
I'm just going to sit back and enjoy the show. Watching upper and middle management for the next 9 months be consumed with trying to build alliances, change political positions, posture and kiss Pfizer's management asses. All 2015 goals will be ignored, no one will be held accountable for anything because management is waiting for Pfizer to set a new direction leaving all of us in limbo. All management will be focused on themselves. So, I can sit back and surf the net, look for a new job, come to work late/leave early and take as many "sick days" as I want.

It will be the best comedy to watch and we will be pulling a paycheck to watch. How great is that!

Then for the next 6 months after that, we will be watching Pfizer up and comings posture themselves to expand their kingdom and influence with Hospira business. Hospira management will run around tying to figure out which Pfizer management to gamble on and kiss their ass.

So, I have a good year to sit back, laugh, take all the latitude I can get and get paid for it. By then I'll have a great job lined up with a new company. Thanks Hospira!!!!
 






Anonymous said:
I'm just going to sit back and enjoy the show. Watching upper and middle management for the next 9 months be consumed with trying to build alliances, change political positions, posture and kiss Pfizer's management asses. All 2015 goals will be ignored, no one will be held accountable for anything because management is waiting for Pfizer to set a new direction leaving all of us in limbo. All management will be focused on themselves. So, I can sit back and surf the net, look for a new job, come to work late/leave early and take as many "sick days" as I want.

It will be the best comedy to watch and we will be pulling a paycheck to watch. How great is that!

Then for the next 6 months after that, we will be watching Pfizer up and comings posture themselves to expand their kingdom and influence with Hospira business. Hospira management will run around tying to figure out which Pfizer management to gamble on and kiss their ass.

So, I have a good year to sit back, laugh, take all the latitude I can get and get paid for it. By then I'll have a great job lined up with a new company. Thanks Hospira!!!!
Click to expand...


Thank you for expressing a very honest and accurate assessment of our situation. Pfizer will dump 95% of us within the first six mos? and 99% of us by the end of the first year. We will be fed more bullshit about performance, focus, live in the present, etc. all , as you stated very well, for the benefit of management to look good. They are so stupid to think Pfizer will actually keep them. Pfizer wants their own robots they have trained and indoctrinated, not Hospira fools. As they all run around kissing each other's asses, we will be enjoying a 10-12 month paid vacation.
It will be comical to watch the comedic circus that will unfold as we move along to our demise.
Getting payed to watch this is almost as good as being a gov't worker! I will hate giving up such a lucrative gig.
 






Anonymous said:
I'm just going to sit back and enjoy the show. Watching upper and middle management for the next 9 months be consumed with trying to build alliances, change political positions, posture and kiss Pfizer's management asses. All 2015 goals will be ignored, no one will be held accountable for anything because management is waiting for Pfizer to set a new direction leaving all of us in limbo. All management will be focused on themselves. So, I can sit back and surf the net, look for a new job, come to work late/leave early and take as many "sick days" as I want.

It will be the best comedy to watch and we will be pulling a paycheck to watch. How great is that!

Then for the next 6 months after that, we will be watching Pfizer up and comings posture themselves to expand their kingdom and influence with Hospira business. Hospira management will run around tying to figure out which Pfizer management to gamble on and kiss their ass.

So, I have a good year to sit back, laugh, take all the latitude I can get and get paid for it. By then I'll have a great job lined up with a new company. Thanks Hospira!!!!
Click to expand...


Thank you for expressing a very honest and accurate assessment of our situation. Pfizer will dump 95% of us within the first six mos? and 99% of us by the end of the first year. We will be fed more bullshit about performance, focus, live in the present, etc. all , as you stated very well, for the benefit of management to look good. They are so stupid to think Pfizer will actually keep them. Pfizer wants their own robots they have trained and indoctrinated, not Hospira fools. As they all run around kissing each other's asses, we will be enjoying a 10-12 month paid vacation.
It will be comical to watch the comedic circus that will unfold as we move along to our demise.
Getting payed to watch this is almost as good as being a gov't worker! I will hate giving up such a lucrative gig.
 






























Advice is simple. Update your resume and be prepared to look for a new career path. At this point we all know it is a possibility. And say a little prayer for those who laugh and wish the worst and make jokes. They will eventually have their judgement day.
 






Anonymous said:
Will the people making infusion pumps survive? Pzifer do not make medical devices and can't just reassign their own personnel to those Hospira positions.
Click to expand...

Pfizer makes medical devices, just not a lot. The epi-pen manufacturing in St. Louis, MO is an example. It really depends on how crowded the market is when you ask if they'd keep the infusion pump business. If it isn't kept, it would be sold, not closed.
 






Anonymous said:
Pfizer makes medical devices, just not a lot. The epi-pen manufacturing in St. Louis, MO is an example. It really depends on how crowded the market is when you ask if they'd keep the infusion pump business. If it isn't kept, it would be sold, not closed.
Click to expand...

Remember that infusion pumps also contains a significant content of electronic components and software, as well as complex mechanical machinery. Epipen seems to be a type of injection needle - that is orders of magnitude simpler than an infusion pump. With electronics, sources of components are always drying up because of the obsolescence, so the process of updating is constant. The software can also get really tricky to maintain over time because of patches. Unless Pfizer has a comparable product, IMHO I would say they do not have the people to replace those already doing the work.
 






Anonymous said:
Remember that infusion pumps also contains a significant content of electronic components and software, as well as complex mechanical machinery. Epipen seems to be a type of injection needle - that is orders of magnitude simpler than an infusion pump. With electronics, sources of components are always drying up because of the obsolescence, so the process of updating is constant. The software can also get really tricky to maintain over time because of patches. Unless Pfizer has a comparable product, IMHO I would say they do not have the people to replace those already doing the work.
Click to expand...

Yes, I should have been clearer in my response. You are correct. I was just pointing out their are med devices in Pfizer's portfolio. You're right, though. it is a bit of apples v. oranges.

I think the issue will be if selling the pumps enhances the sale of the compounds it delivers. Not trying to over simplify, but it is much like the Keurig model. The machines sell cheap, since they really want to make the profit on the coffee cup/pods.

The issue for the person who originally asked really is "will I have a job?" My personal experience tells me they will, but Pfizer will sell the business and the new owner will have bigger plans for the electronic device business. That's a good thing.

Thanks for a logical response. It isn't a CP norm. Good luck to you!
 






Anonymous said:
Yes, I should have been clearer in my response. You are correct. I was just pointing out their are med devices in Pfizer's portfolio. You're right, though. it is a bit of apples v. oranges.

I think the issue will be if selling the pumps enhances the sale of the compounds it delivers. Not trying to over simplify, but it is much like the Keurig model. The machines sell cheap, since they really want to make the profit on the coffee cup/pods.

The issue for the person who originally asked really is "will I have a job?" My personal experience tells me they will, but Pfizer will sell the business and the new owner will have bigger plans for the electronic device business. That's a good thing.

Thanks for a logical response. It isn't a CP norm. Good luck to you!
Click to expand...

Yes, it is sort of like the ink-jet printer business. The printer companies make their money on the disposables, like the ink-jet cartridges. With infusion pumps, they do have model-specific disposable plastic tube-sets that must be used in conjunction with the IV drugs. I've heard these tube-sets aren't cheap either but that doesn't necessarily mean there is a big profit margin.
I agree that Pfizer will likely sell the infusion pump business. They are like a gasoline company. Pfizer just want to sell drugs, and they don't care whose pump uses it. If they choose to get into the pump business, they have to deal with the problems of looking after the existing Hospira pumps in the field, of which there are 100s of thousands. They are probably aware of the checkered history of some of these products. There is also at least one active wrongful death lawsuit to deal with.

No, I thank you for a logical and dignified discourse. CP can be abused or it can be an embodiment of a cyber Greek Chorus - to explain and to give advice and to discuss ideas.
 






Pfizer didn't buy Hospira for their IV infusion pump business! These electromechanical devices don't fit into their portfolio - other Hospira officials products do, though, especially the biosimilars. They will most likely sell off the infusion pump business fairly quickly as this isn't something they want in their portfolio with all the problems Hospira has had with them with the FDA. So you may buy yourself a little bit of time if you are in this device business, but then you will be at the mercy of whoever buys you. Pfizer breaks up companies for what products they want and sells off quickly what they don't. They didn't buy Horpira for its people/talent base. You should play it smart and start looking now for other job opportunities.
 






Anonymous said:
Yes, I should have been clearer in my response. You are correct. I was just pointing out their are med devices in Pfizer's portfolio. You're right, though. it is a bit of apples v. oranges.

I think the issue will be if selling the pumps enhances the sale of the compounds it delivers. Not trying to over simplify, but it is much like the Keurig model. The machines sell cheap, since they really want to make the profit on the coffee cup/pods.

The issue for the person who originally asked really is "will I have a job?" My personal experience tells me they will, but Pfizer will sell the business and the new owner will have bigger plans for the electronic device business. That's a good thing.

Thanks for a logical response. It isn't a CP norm. Good luck to you!
Click to expand...

You poor idiots. I no longer work for Hospira but observe from afar the demise I saw coming of what could have been an awesome company at spin to a train wreck. The only thing Pfizer wants from Hospira is it's progress on implementing biosimiliars, most of which are not in the USA. They want the offshore manufacturing and our pipeline of customer base when they can launch in this country. That will not be 2016 or even the year after. They will sell off anything that does not meet their bottom line, including most sales reps. Generic sales reps typically have a customer base of several states, not several cities and Pfizer has long established itself as a company who does an annual cleanse of several hundreds of thousands of sales reps and other employees. Read Wall St or Bloomberg. Their long term plan has been to buy and divide, has been for quite a while.
 






Anonymous said:
Pfizer didn't buy Hospira for their IV infusion pump business! These electromechanical devices don't fit into their portfolio - other Hospira officials products do, though, especially the biosimilars. They will most likely sell off the infusion pump business fairly quickly as this isn't something they want in their portfolio with all the problems Hospira has had with them with the FDA. So you may buy yourself a little bit of time if you are in this device business, but then you will be at the mercy of whoever buys you. Pfizer breaks up companies for what products they want and sells off quickly what they don't. They didn't buy Horpira for its people/talent base. You should play it smart and start looking now for other job opportunities.
Click to expand...

You are right on in everything you say. Think of this logically. Would you keep a business unit that is so plagued with problems and high maintenance? The cost of cleaning of history and maintaining / upgrading software alone will be costly, not to mention liabilities and please don't forget the medical device tax now imposed. IT'S ALL ABOUT THE MONEY, all else falls to the wayside including impact on current Hospira employees lives
 






I think the younger employees will fair better than the seasoned one because they understand the current business culture better --- working for a company is a contract that lasts only as long as it is mutually beneficial--- the whole company "family" culture has been gone for years. The younger generation keeps up their resume, moves onto other companies every 2-4 years to keep current and diverse. They know few will gain progressive skills long term from a company -- it is cheaper for the company to buy/hire it than spend the money/time to grow it in-house.

Good luck in your future everyone!
 
























Perhaps we're trying to read tea leaves when we should be listening ...

From FiercePharma:

"Also in 2015, Pfizer broke the short winter dry spell in med tech deals by purchasing Hospira ($HSP) for $17 billion. The deal was primarily driven by that company's biosimilar pipeline, but Pfizer CEO Ian Read felt compelled to tell investors that he likes Hospira's infusion pumps business and intends to continue managing it."

If there were any doubt about keeping the business, Read would have simply been silent on the matter. There was no compelling reason to even mention it. I'm sure there will be a chorus of naysayers screaming "CEOs lie." Ok, perhaps true. But they are also smart enough to just avoid controversial topics, like closing parts of acquired companies.

If there was no interest in the business, the answer would have been more like "we're weighing our options with that segment", etc.
 






Top Bottom
Back
Quote